Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLIVEC for Chronic myeloid leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 636 adverse event reports in the FDA FAERS database where GLIVEC was used for Chronic myeloid leukaemia.

Most Reported Side Effects for GLIVEC

Side Effect Reports % Deaths Hosp.
Death 628 63.1% 628 14
Malignant neoplasm progression 60 6.0% 53 12
Gastrointestinal stromal tumour 40 4.0% 30 12
Chronic myeloid leukaemia 38 3.8% 34 6
Anaemia 30 3.0% 18 13
Second primary malignancy 27 2.7% 5 12
Pyrexia 21 2.1% 16 9
Blast crisis in myelogenous leukaemia 20 2.0% 20 3
Dyspnoea 19 1.9% 14 9
Malaise 16 1.6% 7 6
Thrombocytopenia 16 1.6% 10 5
Vomiting 16 1.6% 9 11
Diarrhoea 15 1.5% 6 8
General physical health deterioration 15 1.5% 13 8
Nausea 15 1.5% 10 8

Other Indications for GLIVEC

Gastrointestinal stromal tumour (231) Acute lymphocytic leukaemia (61) Gastrointestinal neoplasm (61) Chromosome analysis abnormal (14) Acute myeloid leukaemia (10) Off label use (6)

Other Drugs Used for Chronic myeloid leukaemia

IMATINIB (18,795) DASATINIB (15,612) NILOTINIB (14,842) PONATINIB (4,723) BOSUTINIB (4,231) ASCIMINIB (1,377) TASIGNA (562) OMACETAXINE MEPESUCCINATE (500) HYDROXYUREA (457) CYTARABINE (241)

Related Pages

GLIVEC Full Profile All Chronic myeloid leukaemia Drugs GLIVEC Demographics GLIVEC Timeline